The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Angiogenic factor and cytokine analysis among patients with renal cell carcinoma treated with adjuvant VEGFR TKIs.
 
Wenxin Xu
No Relationships to Disclose
 
Maneka Puligandla
No Relationships to Disclose
 
Naomi B. Haas
Consulting or Advisory Role - Cerulean Pharma; Exelixis; Janssen Oncology; Novartis; Pfizer
Expert Testimony - Lilly (I)
 
Janice P. Dutcher
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Medarex; Eisai; Merck; Nektar; Prometheus; TRACON Pharma
Speakers' Bureau - Exelixis; Prometheus
Travel, Accommodations, Expenses - Exelixis; Prometheus
 
Robert S. DiPaola
No Relationships to Disclose
 
Rupal Satish Bhatt
Patents, Royalties, Other Intellectual Property - Patent Filed for novel RCC treatments (Inst)